UK markets close in 3 hours 44 minutes

Immunocore Holdings plc (IMCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
58.00-0.47 (-0.80%)
At close: 04:00PM EDT
58.00 0.00 (0.00%)
After hours: 05:31PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
249,428
249,428
174,361
36,484
30,114
Cost of revenue
1,037
1,037
1,089
0
0
Gross profit
248,391
248,391
173,272
36,484
30,114
Operating expenses
Research development
163,545
163,545
101,921
100,248
74,809
Selling general and administrative
144,495
144,495
123,059
110,823
45,740
Total operating expenses
308,040
308,040
224,980
211,071
119,403
Operating income or loss
-59,649
-59,649
-51,708
-174,587
-89,289
Interest expense
5,154
5,154
5,409
5,573
3,109
Total other income/expenses net
-14,073
-14,073
12,478
216
4,332
Income before tax
-60,890
-60,890
-40,883
-179,879
-87,360
Income tax expense
-5,603
-5,603
11,660
150
-13,267
Income from continuing operations
-55,287
-55,287
-52,543
-180,029
-74,093
Net income
-55,287
-55,287
-52,543
-180,029
-74,093
Net income available to common shareholders
-55,287
-55,287
-52,543
-180,029
-74,093
Basic EPS
-1.13
-
-1.15
-4.24
-2.33
Diluted EPS
-1.13
-
-1.15
-4.24
-2.33
Basic average shares
48,510
-
45,715
42,489
31,783
Diluted average shares
48,510
-
45,715
42,489
31,783